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Terpenoid compounds are widely used as biofuels, food 
additives, fragrances and pharmaceuticals. However, 
production of these compounds requires high amounts of 
resources and applicable production pathways are limited. 
The native production pathway for terpenoid compounds in 
Saccharomyces cerevisiae is the mevalonate pathway, which 
leads from acetyl-CoA to isopentenyl diphosphate, the basic 
molecule of which terpenoid compounds are composed of. In 
recent years, several optimization approaches for terpenoid 
production via the mevalonate pathway have been published. 
These optimizations include overexpression of participating 
enzymes by gene amplifi cation or promoter exchange, 
alteration of enzymes, abundant provision of substrates 
and co-factors, and limitation of competing pathways to 
guide fl uxes towards the product of interest. Despite these 
advances, terpenoid production remains cost-intensive, and 
few regulation mechanisms have been exploited so far. To 
tackle these problems, this work aims to utilize metabolic 
modelling strategies to identify alternative pathways, 
implement them in Saccharomyces cerevisiae models, and 
include a model on transcriptional regulation of metabolic 
genes. First, enumeration algorithms are applied on databases 
of known metabolic reactions to fi nd all possible alternative 
pathways connecting the strain metabolites to different key 
terpenoid compounds which serve as precursors to multiple 
other terpenoid compounds. These alternative pathways are 
then introduced into a Yeast 7 model which will be optimized 
to fi nd promising metabolic engineering strategies by utilizing 
OptFlux (Rocha et al. 2010). OptFlux is an extensive metabolic 
modelling platform that offers state of the art strain simulations 
and evolutionary algorithms, enabling the identifi cation of 
benefi cial genetic modifi cations and environmental conditions, 
as well as fl ux analysis throughout a metabolic network. This 
will allow the identifi cation of an optimal metabolic system 
for conduction of alternative terpenoid production pathways. 
Finally, information about transcriptional regulation of metabolic 
genes in Saccharomyces cerevisiae will be used to implement 
a model of Boolean rules, providing an additional regulatory 
layer to enable improved control on fl ux distribution. This 
combined metabolic and regulatory model will be used to 
design Saccharomyces cerevisiae cell factories capable of 
effi cient terpenoid production.
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